Brainsgate Is A Medical Device Company Based In Caesareaisraelfounded In 2000The Company Specializes In Neuromodulation Therapies Aimed At Treating Central Nervous System Disorders Using Its Proprietary Electrical Stimulation Technologywith A Focus On Acute Ischemic Stroke Therapybrainsgate S Implantable Device Stimulates The Spheno Palatine Ganglion To Enhance Cerebral Blood Flowpotentially Reducing Brain Damage Within A Critical 24 Hour Post Symptom Window In Addition To Its Stroke Treatmentbrainsgate Is Exploring Applications For Vascular Dementiathe Company Holds 20 Patentsincluding A Minimally Invasive Implant And Delivery System For Neural Stimulatorsbrainsgate Has Conducted Several Clinical Trialsincluding The Impact 1 Trial And A 300 Patient Studyto Validate The Safety And Efficacy Of Its Technologythe Company Collaborates With Leading Neurology Experts And Is Backed By Notable Investors Such As Boston Scientific And Elron Electronicspositioning Itself As A Pioneer In The Neurovascular Device Sector
